[Korea Biomedical Review] Publishing Pre-clinical Trial Results with GC Labcell
Reaffirming the possibility of NK cell therapy in treating various types of cancer
|Copy URL / Share SNS||
A research team led by Professor Yoon Chae-ok (Department of Bio Engineering) of Hanyang University jointly conducted research with GC Labcell and recently published the pre-clinical trial results for a natural killer (NK) cell treatment (MG4101) for pancreatic cancer.
Considering that an accumulation of extracellular fluid limits the penetration of the treatment into tumors in the case of pancreatic cancer, MG4101 provides a successful outcome in that it efficiently penetrates the tumor and rapidly removes it through cell death and reduction of immunosuppressive factors.
According to the director of GC Labcell, "This study has reaffirmed the possibility of NK cell therapy treating various types of cancer."
Jeon Chae-yun email@example.com
This week's top news
Korean Traditional Colors
Contrast between Korean and English
A 2018 Hanyang University Essay Entrance Exam Science & Engineering Departments
2017 JoongAng Ilbo University Rankings, Seoul Ranked 3rd · ERICA 9th
Korean Couple Culture
[Excellent R&D] BK21 PLUS, Supporting and Fostering Talented Students
[Photo News] Hanyang's Night View
[Researcher of the Month] New Synthesis of Metal-metalloid Material with Improved Catalyst Efficiency and Durability
[Researcher of the Month] The High Mobility of Single-Crystal Nanowires Opens Potential for Future Displays
Kimchi, Korea’s Historical and Conventional Icon